Panaxia and Neuraxpharm to enter new medical cannabis markets in Europe
Both companies will expand their cooperation through the distribution of medical cannabis products in the highly attractive Czech and Swiss markets October 29, 2022 | Yhaoo!
Both companies will expand their cooperation through the distribution of medical cannabis products in the highly attractive Czech and Swiss markets October 29, 2022 | Yhaoo!
July 29, 2022 | The Malta Independent An Israeli medical cannabis company, Panaxia, has announced a €6 million investment and is set to deepen its connection with
May 19, 2022 | Yahoo! Finance Following the adaptation of the European production standard EU-GMP, Panaxia will start production in the local facility in Malta. Obtaining the
April 5, 2022 | BENZINGA – Net Israeli revenues in 2021 increased 38% to 83.6 million. – Initial revenues from medical cannabis oils export from Israel, which
January 3, 2022 | BENZINGA Panaxia Global (TASE: PNAX), which owns medical cannabis company Panaxia Labs Israel Ltd., has obtained official authorization from the EU Health Authority for the EU-GMP standard
December 15, 2021 | I24NEWS i24NEWSDecember 15, 2021, 08:58 PM latest revision December 15, 2021, 08:59 PM i24NEWSAnchor Jeff Smith (R) and Dr. Dadi Segal, Panaxia
December 8, 2021 | BENZINGA Medical cannabis producer Panaxia Labs Israel Ltd. (TASE: PNAX), a subsidiary of Panaxia Global (TASE: PNAX) and Neuraxpharm, a European company that specializes in the central nervous system have launched sales
November 29, 2021 | Yahoo! The company resumed double-digit growth following a decrease in Q2 due to divesting its distribution and logistics operations. Revenues in the
November 3, 2021 | Yahoo! This week, the first export of medical cannabis extracts for inhalation left Israel to Germany, the largest and fastest-growing medical cannabis
September 2, 2021 | Yahoo! In the cumulative first six months of 2021, the company executed retail sales in Germany and Cyprus; Revenues of the 2nd